Literature DB >> 24574065

Complexity in regulation of microRNA machinery components in invasive breast carcinoma.

Sun Young Kwon1, Jae-ho Lee, Bora Kim, Jong-Wook Park, Taeg Kyu Kwon, Sun Hee Kang, Shin Kim.   

Abstract

Altered expression of microRNA (miRNA) machinery components may play an important role in breast cancer progression. The objective of the current study was to evaluate Drosha, the DiGeorge syndrome critical region gene 8 (DGCR8), Dicer, and Argonaute 2 (AGO2) mRNA expression in invasive breast carcinoma (IBC) and to assess the value of clinical parameters on their expression. By using quantitative real-time PCR, we examined the expression of the four miRNA machinery components in 52 breast tumor tissues which are diagnosed as invasive ductal carcinoma and adjacent non-neoplastic tissues. In the present study, decreased mRNA expression levels of major miRNA machinery components were observed in IBC. The altered mRNA expression levels of DGCR8 and AGO2 are positively correlated with to each other. This study revealed for the first time that expression alterations of DGCR8 are significantly associated with estrogen receptor and Ki-67 status in IBC. Moreover, AGO2 mRNA expression level was significantly correlated with N stage. These results provided evidences that down-regulated the four miRNA machinery components may play an important role in breast pathobiology and that DGCR8 and AGO2 might be associated with important clinical factors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24574065     DOI: 10.1007/s12253-014-9750-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  40 in total

Review 1.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

2.  High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Authors:  Dalia M Abd El-Rehim; Graham Ball; Sarah E Pinder; Emad Rakha; Claire Paish; John F R Robertson; Douglas Macmillan; Roger W Blamey; Ian O Ellis
Journal:  Int J Cancer       Date:  2005-09-01       Impact factor: 7.396

3.  Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas.

Authors:  Dionysios J Papachristou; Angeliki Korpetinou; Efstathia Giannopoulou; Anna G Antonacopoulou; Helen Papadaki; Petros Grivas; Chrisoula D Scopa; Haralabos P Kalofonos
Journal:  Virchows Arch       Date:  2011-07-18       Impact factor: 4.064

4.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Dysregulated expression of dicer and drosha in breast cancer.

Authors:  Min Yan; Hong-Yan Huang; Ting Wang; Yi Wan; Shu-De Cui; Zhen-Zhen Liu; Qing-Xia Fan
Journal:  Pathol Oncol Res       Date:  2011-09-07       Impact factor: 3.201

7.  Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Authors:  Torsten O Nielsen; Forrest D Hsu; Kristin Jensen; Maggie Cheang; Gamze Karaca; Zhiyuan Hu; Tina Hernandez-Boussard; Chad Livasy; Dave Cowan; Lynn Dressler; Lars A Akslen; Joseph Ragaz; Allen M Gown; C Blake Gilks; Matt van de Rijn; Charles M Perou
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

8.  Dicer, Drosha, and outcomes in patients with ovarian cancer.

Authors:  William M Merritt; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Whitney A Spannuth; Rosemarie Schmandt; Diana Urbauer; Len A Pennacchio; Jan-Fang Cheng; Alpa M Nick; Michael T Deavers; Alexandra Mourad-Zeidan; Hua Wang; Peter Mueller; Marc E Lenburg; Joe W Gray; Samuel Mok; Michael J Birrer; Gabriel Lopez-Berestein; Robert L Coleman; Menashe Bar-Eli; Anil K Sood
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

Review 9.  Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.

Authors:  Leslie K Diaz; Vincent L Cryns; W Fraser Symmans; Nour Sneige
Journal:  Adv Anat Pathol       Date:  2007-11       Impact factor: 3.875

10.  mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer.

Authors:  Chao Cheng; Xuping Fu; Pedro Alves; Mark Gerstein
Journal:  Genome Biol       Date:  2009-09-01       Impact factor: 13.583

View more
  13 in total

1.  Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.

Authors:  Penn Muluhngwi; Abirami Krishna; Stephany L Vittitow; Joshua T Napier; Kirsten M Richardson; Mackenzie Ellis; Justin L Mott; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2016-12-13       Impact factor: 8.679

2.  miRNA biogenesis-associated RNase III nucleases Drosha and Dicer are upregulated in colorectal adenocarcinoma.

Authors:  Shin Kim; Mei Ling Song; Hyeonji Min; Ilseon Hwang; Seong Kyu Baek; Taeg Kyu Kwon; Jong-Wook Park
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

3.  Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells.

Authors:  Penn Muluhngwi; Kirsten Richardson; Joshua Napier; Eric C Rouchka; Justin L Mott; Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2017-01-28       Impact factor: 4.102

4.  Dysregulated expression of Dicer in invasive ductal breast carcinoma.

Authors:  Ali Akbar Poursadegh Zonouzi; Azim Nejatizadeh; Mohammad Rahmati-Yamchi; Hedieh Fardmanesh; Samira Shakerizadeh; Ahmad Poursadegh Zonouzi; Kazem Nejati-Koshki; Mohammad Shekari
Journal:  Med Oncol       Date:  2015-06-16       Impact factor: 3.064

5.  miRNA clusters as therapeutic targets for hormone-resistant breast cancer.

Authors:  Gianpiero Di Leva; Douglas G Cheung; Carlo M Croce
Journal:  Expert Rev Endocrinol Metab       Date:  2015-10-13

6.  MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?

Authors:  Geraldine Cizeron-Clairac; François Lallemand; Sophie Vacher; Rosette Lidereau; Ivan Bieche; Celine Callens
Journal:  BMC Cancer       Date:  2015-07-05       Impact factor: 4.430

7.  Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.

Authors:  Jaegil Kim; Woo-Jae Park; Kwang-Joon Jeong; Sun Hee Kang; Sun Young Kwon; Shin Kim; Jong-Wook Park
Journal:  Int J Genomics       Date:  2017-03-02       Impact factor: 2.326

8.  Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma.

Authors:  Shahrzad Shadabi; Nargess Delrish; Mehdi Norouzi; Maryam Ehteshami; Fariba Habibian-Sezavar; Samira Pourrezaei; Mobina Madihi; Mohammadreza Ostadali; Foruhar Akhgar; Ali Shayeghpour; Cobra Razavi Pashabayg; Sepehr Aghajanian; Sayed-Hamidreza Mozhgani; Seyed-Mohammad Jazayeri
Journal:  Infect Agent Cancer       Date:  2021-06-29       Impact factor: 2.965

9.  The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading.

Authors:  Roberta Tarallo; Giorgio Giurato; Giuseppina Bruno; Maria Ravo; Francesca Rizzo; Annamaria Salvati; Luca Ricciardi; Giovanna Marchese; Angela Cordella; Teresa Rocco; Valerio Gigantino; Biancamaria Pierri; Giovanni Cimmino; Luciano Milanesi; Concetta Ambrosino; Tuula A Nyman; Giovanni Nassa; Alessandro Weisz
Journal:  Genome Biol       Date:  2017-10-06       Impact factor: 13.583

10.  Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.

Authors:  Hélène Gazon; Gildas Belrose; Marie Terol; Jean-Come Meniane; Jean-Michel Mesnard; Raymond Césaire; Jean-Marie Peloponese
Journal:  Oncotarget       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.